PT  - JOURNAL ARTICLE
AU  - Sanoh, Seigo
AU  - Nozaki, Kazuyoshi
AU  - Murai, Hidetsugu
AU  - Terashita, Shigeyuki
AU  - Teramura, Toshio
AU  - Ohta, Shigeru
TI  - Prediction of Human Metabolism of FK3453 by Aldehyde Oxidase Using Chimeric Mice Transplanted with Human or Rat Hepatocytes
AID  - 10.1124/dmd.111.041954
DP  - 2012 Jan 01
TA  - Drug Metabolism and Disposition
PG  - 76--82
VI  - 40
IP  - 1
4099  - http://dmd.aspetjournals.org/content/40/1/76.short
4100  - http://dmd.aspetjournals.org/content/40/1/76.full
SO  - Drug Metab Dispos2012 Jan 01; 40
AB  - During drug development, it is important to predict the activities of multiple metabolic enzymes, not only cytochrome P450 (P450) but also non-P450 enzymes, such as conjugative enzymes and aldehyde oxidase (AO). In this study, we focused on prediction of AO-mediated human metabolism and pharmacokinetics (PK) of 6-(2-amino-4-phenylpyrimidine-5-yl)-2-isopropylpyridazin-3(2H)-one (FK3453) (Astellas Pharma Inc.), the development of which was suspended due to extremely low exposure in human, despite good oral bioavailability in rat and dog. We examined species difference in oxidative metabolism of the aminopyrimidine moiety of FK3453, catalyzed by AO, using human-chimeric mice with humanized liver (h-PXB mice) and rat-chimeric mice (r-PXB mice) transplanted with rat hepatocytes. AO activity of h-PXB mouse hepatocytes was higher than that of r-PXB mouse hepatocytes. Moreover, higher concentrations of human-specific AO-generated FK3453 metabolite A-M were detected in urine and feces after administration of FK3453 to h-PXB mice versus r-PXB mice. The total clearance of h-PXB mice was 2-fold higher than that of r-PXB mice. These results agreed reasonably well with the metabolism and PK profiles of FK3453 in human and rat. Our results indicated that h-PXB mice should be helpful for predicting the metabolic profile of drugs in humans, and the use of both h-PXB and r-PXB mice should be helpful for evaluation of species differences of AO metabolic activity.